Kazia Therapeutics (KZIA) investor group reports 4.6% beneficial stake via ADS

Rhea-AI Filing Summary

Kazia Therapeutics Limited is reported to have 264,980,500 Ordinary Shares beneficially owned by Lynwood Opportunities Master Fund, Lynwood Capital Management Inc., and Ben Shapiro, as of June 30, 2026. This represents 4.6% of the 5,713,449,734 Ordinary Shares outstanding as of March 12, 2026.

The shares are held through the issuer’s American Depositary Shares, with each ADS representing 500 Ordinary Shares. Each reporting person has sole voting and dispositive power over the reported shares and confirms ownership of 5 percent or less of the class. The reporting persons disclaim beneficial ownership beyond the shares directly held by each.

Key Figures

Beneficially owned Ordinary Shares: 264,980,500 Ordinary Shares Ownership percentage: 4.6% Shares outstanding: 5,713,449,734 Ordinary Shares +2 more

5 metrics

Beneficially owned Ordinary Shares 264,980,500 Ordinary Shares Beneficially owned by each reporting person as of June 30, 2026

Ownership percentage 4.6% Percentage of class based on 5,713,449,734 Ordinary Shares outstanding as of March 12, 2026

Shares outstanding 5,713,449,734 Ordinary Shares Outstanding as of March 12, 2026, as reported by the issuer

ADS to Ordinary Share ratio 500 Ordinary Shares per ADS Each American Depositary Share represents 500 Ordinary Shares

Sole voting power 264,980,500.00 Sole voting power reported for each reporting person

Key Terms

beneficially owns, American Depositary Shares, sole dispositive power, disclaims beneficial ownership, +1 more

5 terms

beneficially owns financial

"The Fund directly beneficially owns the Ordinary Shares reported in this Statement."

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

American Depositary Shares financial

"The Reporting Persons own Ordinary Shares through the Issuer's American Depositary Shares, each representing five hundred (500) Ordinary Shares."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

sole dispositive power financial

"7 | Sole Dispositive Power 264,980,500.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

disclaims beneficial ownership financial

"Each Reporting Person disclaims beneficial ownership with respect to any Ordinary Shares other than the Ordinary Shares directly beneficially owned"

percent of class financial

"Percent of class: See Item 11 on the cover page for each Reporting Person."

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What percentage of Kazia Therapeutics (KZIA) does Lynwood report owning?

Lynwood-related reporting persons state beneficial ownership of 4.6% of Kazia Therapeutics’ 5,713,449,734 Ordinary Shares outstanding as of March 12, 2026, based on issuer data cited in the filing.

How many Kazia Therapeutics (KZIA) shares are beneficially owned by Lynwood and affiliates?

The reporting persons disclose beneficial ownership of 264,980,500 Ordinary Shares of Kazia Therapeutics, held through American Depositary Shares, as of the close of business on June 30, 2026.

How are Kazia Therapeutics (KZIA) American Depositary Shares structured?

The report states that Kazia Therapeutics’ American Depositary Shares each represent 500 Ordinary Shares. The CUSIP 48669G303 applies to the ADS, while the Ordinary Shares themselves do not have a CUSIP.

Who are the reporting persons in this Kazia Therapeutics (KZIA) Schedule 13G/A?

The filing lists Lynwood Capital Management Inc., Ben Shapiro, and Lynwood Opportunities Master Fund as reporting persons, with the Fund directly holding the Ordinary Shares and the manager and Mr. Shapiro deemed beneficial owners.

Does the Kazia Therapeutics (KZIA) filing indicate control or shared voting power?

Each reporting person reports sole voting and sole dispositive power over 264,980,500 Ordinary Shares, and no shared voting or dispositive power, indicating individual control over the reported position.

What does the Kazia Therapeutics (KZIA) filing say about owning less than 5%?

The document includes an “Ownership of 5 percent or less of a class” statement, confirming that the reporting persons’ 4.6% beneficial ownership is at or below the 5% threshold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:18 PM Accepted by SEC EDGAR 08/14/2026 - 04:07 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Kazia Therapeutics Limited

(Name of Issuer)

Ordinary Shares, no par value per share

(Title of Class of Securities)

48669G303

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 48669G303

1

Names of Reporting Persons

Lynwood Capital Management Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ONTARIO, CANADA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 264,980,500.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 264,980,500.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

264,980,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP Number(s): 48669G303

1

Names of Reporting Persons

Ben Shapiro

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CANADA (FEDERAL LEVEL)

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 264,980,500.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 264,980,500.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

264,980,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP Number(s): 48669G303

1

Names of Reporting Persons

Lynwood Opportunities Master Fund

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 264,980,500.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 264,980,500.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

264,980,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.6 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Kazia Therapeutics Limited
(b)	Address of issuer's principal executive offices: Three International Towers Level 24, 300 Barangaroo Avenue, Sydney, New South Wales, Australia, 2000
Item 2.
(a)	Name of person filing: This Schedule 13G (this "Statement" or this "Schedule 13G") is being filed by: (1) Lynwood Capital Management Inc., an Ontario corporation (the "Investment Manager"); (2) Ben Shapiro ("Mr. Shapiro"); and (3) Lynwood Opportunities Master Fund, a Cayman Islands entity (the "Fund") (all of the foregoing, collectively, the "Reporting Persons"). The Fund is an investment vehicle. The Fund directly beneficially owns the Ordinary Shares (as defined below) reported in this Statement. The Investment Manager is the investment manager of the Fund. Mr. Shapiro is the President, Chief Executive Officer, Chief Investment Officer, sole director and indirect controlling stockholder of the Investment Manager. Mr. Shapiro and the Investment Manager may be deemed to beneficially own the Ordinary Shares directly beneficially owned by the Fund. Each Reporting Person disclaims beneficial ownership with respect to any Ordinary Shares other than the Ordinary Shares directly beneficially owned by such Reporting Person.
(b)	Address or principal business office or, if none, residence: The principal business office of the Fund is FG Services Limited, Suite 2206, Cassia Court, 72 Market Street, Camana Bay, P.O. Box 30869, Grand Cayman KY1-1204, Cayman Islands. The principal business office of the Investment Manager and Mr. Shapiro is 200 Bay St, Suite 1304, Royal Bank Plaza, South Tower, Toronto, Ontario M5J 2J1.
(c)	Citizenship: For citizenship or place of organization see Item 4 of the cover page of each Reporting Person.
(d)	Title of class of securities: Ordinary Shares, no par value per share
(e)	CUSIP No.: 48669G303
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Item 9 on the cover page for each Reporting Person, and Item 2, which information is given as of the close of business on June 30, 2026, the Date of Event which requires the filing of this Schedule 13G. The Reporting Persons own Ordinary Shares through the Issuer's American Depositary Shares, each representing five hundred (500) Ordinary Shares. The Ordinary Shares have no CUSIP number. The CUSIP number for the Issuer's American Depositary Shares is 48669G303.
(b)	Percent of class: See Item 11 on the cover page for each Reporting Person. The percentages of beneficial ownership contained herein are based on 5,713,449,734 Ordinary Shares outstanding as of March 12, 2026 as reported by the Issuer in a Form F-3 filed with the SEC on March 18, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Item 5 on the cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Item 6 on the cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Item 7 on the cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Item 8 on the cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lynwood Capital Management Inc.

Signature:	/s/ Ben Shapiro
Name/Title:	Ben Shapiro / Authorized Signatory
Date:	08/14/2026

Ben Shapiro

Signature:	/s/ Ben Shapiro
Name/Title:	N/A
Date:	08/14/2026

Lynwood Opportunities Master Fund

Signature:	/s/ Ben Shapiro
Name/Title:	Ben Shapiro / Authorized Signatory
Date:	08/14/2026